|
EP0330801A1
(en)
*
|
1983-02-08 |
1989-09-06 |
Schering Aktiengesellschaft |
Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
|
|
US4735796A
(en)
*
|
1983-12-08 |
1988-04-05 |
Gordon Robert T |
Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
|
|
US5401491A
(en)
*
|
1984-05-31 |
1995-03-28 |
Guerbet S.A. |
NMR contrast agents
|
|
PT81498B
(pt)
*
|
1984-11-23 |
1987-12-30 |
Schering Ag |
Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas
|
|
US5746999A
(en)
*
|
1984-11-23 |
1998-05-05 |
Schering Aktiengesellschaft |
Magnetic particles for diagnostic purposes
|
|
DE3614142C2
(de)
*
|
1985-04-26 |
1996-03-28 |
Toshiba Kawasaki Kk |
Verwendung eines Materials für die Diagnose durch Kernresonanz-Spektroskopie
|
|
US4795698A
(en)
*
|
1985-10-04 |
1989-01-03 |
Immunicon Corporation |
Magnetic-polymer particles
|
|
US5336762A
(en)
*
|
1985-11-18 |
1994-08-09 |
Access Pharmaceuticals, Inc. |
Polychelating agents for image and spectral enhancement (and spectral shift)
|
|
EP0247156B1
(en)
*
|
1985-11-18 |
1993-06-23 |
Access Pharmaceuticals Inc. |
Polychelating agents for image and spectral enhancement (and spectral shift)
|
|
MX174467B
(es)
*
|
1986-01-23 |
1994-05-17 |
Squibb & Sons Inc |
1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
|
|
EP0232751B1
(en)
*
|
1986-01-23 |
1991-09-11 |
E.R. Squibb & Sons, Inc. |
1-substituted-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
|
|
US4885363A
(en)
*
|
1987-04-24 |
1989-12-05 |
E. R. Squibb & Sons, Inc. |
1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
|
|
IT1213029B
(it)
*
|
1986-01-30 |
1989-12-07 |
Bracco Ind Chimica Spa |
Chelati di ioni metallici paramagnetici.
|
|
US5248492A
(en)
*
|
1986-07-03 |
1993-09-28 |
Advanced Magnetics, Inc. |
Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
|
|
US5102652A
(en)
*
|
1986-07-03 |
1992-04-07 |
Advanced Magnetics Inc. |
Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
|
|
US4827945A
(en)
*
|
1986-07-03 |
1989-05-09 |
Advanced Magnetics, Incorporated |
Biologically degradable superparamagnetic materials for use in clinical applications
|
|
DE3625417C2
(de)
*
|
1986-07-28 |
1998-10-08 |
Schering Ag |
Tetraazacyclododecan-Derivate
|
|
US5567411A
(en)
*
|
1986-11-10 |
1996-10-22 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group
|
|
US5252317A
(en)
*
|
1986-11-10 |
1993-10-12 |
The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid
|
|
US5707604A
(en)
*
|
1986-11-18 |
1998-01-13 |
Access Pharmaceuticals, Inc. |
Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
|
|
IT1224416B
(it)
*
|
1987-12-24 |
1990-10-04 |
Bracco Ind Chimica Spa |
Chelanti macrociclici e loro chelati
|
|
DE3709851A1
(de)
*
|
1987-03-24 |
1988-10-06 |
Silica Gel Gmbh Adsorptions Te |
Nmr-diagnostische fluessigkeitszusammensetzungen
|
|
DE3710730A1
(de)
*
|
1987-03-31 |
1988-10-20 |
Schering Ag |
Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
|
|
FR2614020B1
(fr)
*
|
1987-04-14 |
1989-07-28 |
Guerbet Sa |
Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
|
|
US5154179A
(en)
*
|
1987-07-02 |
1992-10-13 |
Medical Magnetics, Inc. |
Device construction and method facilitating magnetic resonance imaging of foreign objects in a body
|
|
US4927624A
(en)
*
|
1987-11-19 |
1990-05-22 |
The University Of Rochester |
Clay magnetic resonance contrast agents for gastrointestinal comsumption or introduction
|
|
GB8813144D0
(en)
*
|
1988-06-03 |
1988-07-06 |
Nycomed As |
Compositions
|
|
JPH0678247B2
(ja)
*
|
1988-10-04 |
1994-10-05 |
大塚製薬株式会社 |
Ｎｍｒ造影用鉄含有製剤
|
|
US5702683A
(en)
*
|
1989-01-24 |
1997-12-30 |
The United States Of America As Represented By The United States Department Of Energy |
Nuclear magnetic resonance contrast agents
|
|
JPH0810375B2
(ja)
*
|
1989-04-12 |
1996-01-31 |
キヤノン株式会社 |
定着装置
|
|
GB8916782D0
(en)
*
|
1989-07-21 |
1989-09-06 |
Nycomed As |
Compositions
|
|
US5393525A
(en)
*
|
1989-07-21 |
1995-02-28 |
Nycomed Imaging As |
Contrast medium comprising superparamagnetic or ferromagnetic particles capable of increasing viscosity after administration
|
|
GB8916781D0
(en)
*
|
1989-07-21 |
1989-09-06 |
Nycomed As |
Compositions
|
|
GB8916780D0
(en)
*
|
1989-07-21 |
1989-09-06 |
Nycomed As |
Compositions
|
|
KR0149014B1
(ko)
*
|
1989-09-27 |
1998-10-15 |
오쓰카세이야쿠가부시키가이샤 |
Nmr 조영용 철 함유 제제
|
|
US5120527A
(en)
*
|
1989-10-19 |
1992-06-09 |
King Chuen Peter Li |
Paramagnetic oil emulsions as mri contrast agents
|
|
US5064636A
(en)
*
|
1989-10-19 |
1991-11-12 |
Li King C P |
Paramagnetic oil emulsions as enteric MRI contrast agents
|
|
US5368840A
(en)
*
|
1990-04-10 |
1994-11-29 |
Imarx Pharmaceutical Corp. |
Natural polymers as contrast media for magnetic resonance imaging
|
|
ES2138122T3
(es)
*
|
1990-04-10 |
2000-01-01 |
Imarx Pharmaceutical Corp |
Polimeros como medios de contraste para resonancia magnetica.
|
|
US5268165A
(en)
*
|
1990-10-16 |
1993-12-07 |
Biomedical Frontiers, Inc. |
Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
|
|
US5885549A
(en)
*
|
1991-02-01 |
1999-03-23 |
Imarx Pharmaceutical Corp. |
Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
|
|
US5143716A
(en)
*
|
1991-02-01 |
1992-09-01 |
Unger Evan C |
Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
|
|
US5240693A
(en)
*
|
1991-05-01 |
1993-08-31 |
University Of New Mexico |
Image enhancement by coadministration of biomodulators and structurally modified imaging agents
|
|
EP0673655A1
(en)
*
|
1992-03-19 |
1995-09-27 |
Daikin Industries, Limited |
Mri contrast medium and diagnostic method
|
|
JPH06157355A
(ja)
*
|
1992-11-13 |
1994-06-03 |
Dai Ichi Seiyaku Co Ltd |
Ｍｒｉ用粒状製剤
|
|
US6106866A
(en)
*
|
1995-07-31 |
2000-08-22 |
Access Pharmaceuticals, Inc. |
In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
|
|
US5861140A
(en)
*
|
1996-11-20 |
1999-01-19 |
Hoechst Celanese Corp. |
Tripodal paramagnetic contrast agents for MR imaging
|
|
US5861138A
(en)
*
|
1996-11-20 |
1999-01-19 |
Hoechst Celanese Corp. |
Ligands for MRI contrast agent
|
|
US5820851A
(en)
*
|
1997-08-21 |
1998-10-13 |
Hoechst Celanese Corporation |
Tripodal pyridine ligands as MRI contrast agents
|
|
US5858329A
(en)
*
|
1997-08-21 |
1999-01-12 |
Hoechst Celanese Corporation |
MRI diagnostic procedures using tripodal pyridinyl metal complexes
|
|
US5869026A
(en)
*
|
1997-08-21 |
1999-02-09 |
Hoechst Celanese Corp. |
Tripodal carboxamide ligands for MRI contrast agents
|
|
US5824288A
(en)
*
|
1997-08-21 |
1998-10-20 |
Hoechst Celanese Corporation |
Thio-substituted pyridines as MRI ligand precursors
|
|
US5869025A
(en)
*
|
1997-08-21 |
1999-02-09 |
Hoechst Celanese Corporation |
Tripodal aromatic heterocycle carboxamide MRI contrast agents
|
|
US5980863A
(en)
*
|
1998-11-02 |
1999-11-09 |
Eagle Vision Pharmaceutical Corporation |
Manganese compositions and methods for MRI
|
|
AR036354A1
(es)
*
|
2001-08-31 |
2004-09-01 |
Takeda Chemical Industries Ltd |
Preparacion solida
|
|
EP1458328B1
(en)
*
|
2001-11-21 |
2013-01-30 |
Bracco Diagnostics Inc. |
Formulations comprising locust bean gum as stabilizing agent and mannitol as osmotic agent for use in medical or diagnostic procedures
|